Mehmet Uzunel

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CLINICAL TRANSPLANTATION. 2019;33(6):e13537
The importance of graft cell composition in outcome after allogeneic stem cell transplantation in patients with malignant disease
Svenberg P; Wang T; Uhlin M; Watz E; Remberger M; Ringden O; Mattsson J; Uzunel M
Article: BMC PEDIATRICS. 2018;18(1):285
Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report
Lundin KE; Wang Q; Hamasy A; Marits P; Uzunel M; Wirta V; Wikstrom A-C; Fasth A; Ekwall O; Smith CIE
Article: PEDIATRIC TRANSPLANTATION. 2016;20(5):667-674
Improved overall survival for pediatric patients undergoing allogeneic hematopoietic stem cell transplantation - A comparison of the last two decades
Svenberg P; Remberger M; Uzunel M; Mattsson J; Gustafsson B; Fjaertoft G; Sundin M; Winiarski J; Ringden O
Article: PLOS ONE. 2016;11(5):e0154737
Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?
Stikvoort A; Sundin M; Uzunel M; Gertow J; Sundberg B; Schaffer M; Mattsson J; Uhlin M
Article: CYTOTHERAPY. 2015;17(12):1732-1745
Xeno-immunosuppressive properties of human decidual stromal cells in mouse models of alloreactivity in vitro and in vivo
Sadeghi B; Heshmati Y; Khoein B; Kaipe H; Uzunel M; Walfridsson J; Ringden O
Article: CELL METABOLISM. 2015;22(3):408-417
Transplanted Bone Marrow-Derived Cells Contribute to Human Adipogenesis
Ryden M; Uzunel M; Hard JL; Borgstrom E; Mold JE; Arner E; Mejhert N; Andersson DP; Widlund Y; Hassan M; Jones CV; Spalding KL; Svahn B-M; Ahmadian A; Frisen J; Bernard S; Mattsson J; Arner P
Article: PEDIATRIC BLOOD AND CANCER. 2015;62(5):890-896
Hypogammaglobulinemia in Children after Allogeneic Hematopoietic Stem Cell Transplantation: A Cytokine Mediated Immunoglobulin Isotype Class Switch Arrest?
Sundin M; Remberger M; Lindqvist H; Omazic B; Sundberg B; Uzunel M; Winiarski J
Article: IMMUNOLOGY. 2015;144(4):687-703
Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors
Bergstrom S-E; Uzunel M; Talme T; Bergdahl E; Sundqvist K-G
Article: JOURNAL OF INFLAMMATION RESEARCH. 2015;8:149-160
An ex vivo RT-qPCR-based assay for human peripheral leukocyte responsiveness to glucocorticoids in surgically induced inflammation.
Gråberg T; Strömmer L; Hedman E; Uzunel M; Ehrenborg E; Wikström A-C
Article: STEM CELLS AND DEVELOPMENT. 2014;23(14):1559-1567
T-Cell Receptor Excision Circle Levels After Allogeneic Stem Cell Transplantation Are Predictive of Relapse in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
Uzunel M; Sairafi D; Remberger M; Mattsson J; Uhlin M
Article: JOURNAL OF IMMUNOLOGY RESEARCH. 2014;2014:578741-14
Alpha/Beta T-Cell Depleted Grafts as an Immunological Booster to Treat Graft Failure after Hematopoietic Stem Cell Transplantation with HLA-Matched Related and Unrelated Donors
Radestad E; Wikell H; Engstrom M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
Article: STEM CELLS. 2013;31(3):592-601
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Ringden O; Erkers T; Nava S; Uzunel M; Iwarsson E; Conrad R; Westgren M; Mattsson J; Kaipe H
Article: PLOS ONE. 2013;8(9):e74534
A Research Study of the Association between Maternal Microchimerism and Systemic Lupus Erythematosus in Adults: A Comparison between Patients and Healthy Controls Based on Single-Nucleotide Polymorphism Using Quantitative Real-Time PCR
Kanold AMJ; Svenungsson E; Gunnarsson I; Gotherstrom C; Padyukov L; Papadogiannakis N; Uzunel M; Westgren M
Article: TRANSPLANTATION. 2012;94(10):1066-1074
Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation
Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringden O; Uhlin M; Mattsson J
Article: CLINICAL INFECTIOUS DISEASES. 2012;55(8):1064-1073
Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease
Uhlin M; Gertow J; Uzunel M; Okas M; Berglund S; Watz E; Brune M; Ljungman P; Maeurer M; Mattsson J
Article: STEM CELLS. 2012;30(7):1575-1578
Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
von Bahr L; Batsis I; Moll G; Hagg M; Szakos A; Sundberg B; Uzunel M; Ringden O; Le Blanc K
Article: STEM CELLS AND DEVELOPMENT. 2012;21(9):1409-1417
Mesenchymal Stem Cells Inhibit Thymic Reconstitution After Allogeneic Cord Blood Transplantation
Uhlin M; Sairafi D; Berglund S; Thunberg S; Gertow J; Ringden O; Uzunel M; Remberger M; Mattsson J
Article: CLINICAL IMMUNOLOGY. 2012;142(3):343-350
Thymic function after allogeneic stem cell transplantation is dependent on graft source and predictive of long term survival
Sairafi D; Mattsson J; Uhlin M; Uzunel M
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(6):503-509
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders
Ringden O; Remberger M; Dahllof G; Garming-Legert K; Karlsson H; Svenberg P; Uhlin M; Uzunel M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2010;162(1):146-155
Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation
Gertow J; Berglund S; Okas M; Uzunel M; Berg L; Karre K; Mattsson J; Uhlin M
Article: PEDIATRIC RESEARCH. 2010;68(3):199-204
Maternal Microchimerism in Juvenile Tonsils and Adenoids
Jonsson AM; Papadogiannakis N; Granath A; Haggstrom J; Schaffer M; Uzunel M; Westgren M
Article: CANCER IMMUNOLOGY, IMMUNOTHERAPY. 2010;59(3):473-477
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation
Uhlin M; Okas M; Gertow J; Uzunel M; Brismar TB; Mattsson J
Article: JOURNAL OF IMMUNOTHERAPY. 2010;33(1):96-105
Clinical Expansion of Cord Blood-derived T Cells for Use as Donor Lymphocyte Infusion After Cord Blood Transplantation
Okas M; Gertow J; Uzunel M; Karlsson H; Westgren M; Karre K; Ringden O; Mattsson J; Uhlin M
Article: BONE MARROW TRANSPLANTATION. 2009;44(11):757-763
Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism
Svenberg P; Mattsson J; Ringden O; Uzunel M
Article: JOURNAL OF IMMUNOTHERAPY. 2009;32(7):755-764
HSCT Recipients Have Specific Tolerance to MSC but not to the MSC Donor
Sundin M; Barrett AJ; Ringden O; Uzunel M; Lonnies H; Dackland A-L; Christensson B; Le Blanc K
Article: LIVER TRANSPLANTATION. 2008;14(12):1793-1802
Evidence for No Relevance of Anti-Major Histocompatibility Complex Class I-Related Chain A Antibodies in Liver Transplantation
Uzunel M; Kasimu H; Joshi M; Ge X; Liu J; Xu B; Jaksch M; Jorns C; Nowak G; Sumitran-Holgersson S
Article: BONE MARROW TRANSPLANTATION. 2008;42(10):643-648
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor
Ringden O; Okas M; Uhlin M; Uzunel M; Remberger M; Mattsson J
Article: BLOOD. 2008;112(3):532-541
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses
Karlsson H; Samarasinghe S; Ball LM; Sundberg B; Lankester AC; Dazzi F; Uzunel M; Rao K; Veys P; Le Blanc K; Ringden O; Amrolia PJ
Article: BONE MARROW TRANSPLANTATION. 2008;41(11):961-964
No impact of NOD2/CARD15 on outcome after SCT
Sairafi D; Uzunel M; Remberger M; Ringden O; Mattsson J
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2008;198(3):325.e1-325.e6
Maternal microchimerism in human fetal tissues
Jonsson AM; Uzunel M; Gotherstrom C; Papadogiannakis N; Westgren M
Article: HUMAN REPRODUCTION. 2008;23(1):139-143
Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient
Mints M; Jansson M; Sadeghi B; Westgren M; Uzunel M; Hassan M; Palmblad J
Article: LEUKEMIA. 2007;21(11):2271-2276
Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon
Ringden O; Uzunel M; Sundberg B; Lonnies L; Nava S; Gustafsson J; Henningsohn L; Le Blanc K
Article: BONE MARROW TRANSPLANTATION. 2007;39(7):383-388
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases
Ringden O; Remberger M; Svenberg P; Svahn B-M; Dahllof G; Gustafsson B; Hassan Z; Omazic B; Uzunel M; Aschan J; Barkholt L; Winiarski J; Ljungman P; Mattsson J
Article: GUT. 2007;56(2):243-252
Human liver sinusoidal endothelial cells induce apoptosis in activated T cells:: a role in tolerance induction
Karrar A; Broome U; Uzunel M; Qureshi AR; Sumitran-Holgersson S
Article: JOURNAL OF VIROLOGY. 2007;81(3):1390-1400
Inhibition of heavy chain and β₂-microglobulin synthesis as a mechanism of major histocompatibility complex class I downregulation during Epstein-Barr virus replication
Guerreiro-Cacais AO; Uzunel M; Levitskaya J; Levitsky V
Article: BLOOD. 2006;108(9):3112-3120
Endogenous thrombospondin-1 is a cell-surface ligand for regulation of integrin-dependent T-lymphocyte adhesion
Li SS; Liu Z; Uzunel M; Sundqvist K-G
Article: TRANSPLANTATION. 2006;82(7):913-919
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning
Uzunel M; Remberger M; Sairafi D; Hassan Z; Mattsson J; Omazic B; Barkholt L; Ringden O
Article: TRANSPLANTATION. 2006;81(10):1390-1397
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease
Ringden O; Uzunel M; Rasmusson I; Remberger M; Sundberg B; Lonnies H; Marschall H-U; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
Article: LIVER TRANSPLANTATION. 2005;11(8):911-921
Biliary epithelial cell antibodies induce expression of Toll-like receptors 2 and 3: A mechanism for post-liver transplantation cholangitis?
Ge XP; Uzunel M; Ericzon BG; Sumitran-Holgersson S
Article: HAEMATOLOGICA. 2005;90(8):1017-1026
Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells
Gotherstrom C; West A; Liden J; Uzunel M; Lahesmaa R; Le Blanc K
Article: CLINICAL TRANSPLANTATION. 2005;19(3):346-349
Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV
Jaksch M; Uzunel M; Remberger M; Sundberg B; Mattsson J
Article: CIRCULATION. 2004;110(24):3699-3707
Expression of vascular endothelial growth factor receptor-2 or Tie-2 on peripheral blood cells defines functionally competent cell Populations capable of reendothelialization
Nowak G; Karrar A; Holmén C; Nava S; Uzunel M; Hultenby K; Sumitran-Holgersson S
Article: TRANSPLANTATION. 2004;78(7):1014-1020
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation
Le Blanc K; Remberger M; Uzunel M; Mansson J; Barkholt L; Ringdén O
Article: TRANSPLANTATION. 2004;78(5):697-703
Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation
Barkholt L; Danielsson R; Calissendorff B; Svensson L; Malihi R; Remberger M; Uzunel M; Thörne A; Ringdén O
Article: THE LANCET. 2004;363(9419):1439-1441
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
Le Blanc K; Rasmusson I; Sundberg B; Götherström C; Hassan M; Uzunel M; Ringdén O
Article: XENOTRANSPLANTATION. 2004;11(2):184-194
Adult porcine islets produce MCP-1 and recruit human monocytes in vitro
Ehrnfelt C; Kumagai-Braesch M; Uzunel M; Holgersson J
Article: BONE MARROW TRANSPLANTATION. 2004;33(1):47-52
Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation
Uzunel M; Ringdén O
Article: AMERICAN JOURNAL OF PATHOLOGY. 2003;163(4):1275-1289
Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis
Xu B; Broome U; Uzunel M; Nava S; Ge XP; Kumagai-Braesch M; Hultenby K; Christensson B; Ericzon BG; Holgersson J; Sumitran-Holgersson S
Article: BONE MARROW TRANSPLANTATION. 2003;32(5):477-483
Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation
Mattsson J; Uzunel M; Remberger M; Hassan M
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2003;122(5):788-794
Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia
Uzunel M; Jaksch M; Mattsson J; Ringdén O
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2003;70(6):384-391
Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation
Remberger M; Jaksch M; Uzunel M; Mattsson J
Article: TRANSPLANTATION. 2003;75(7):1061-1066
Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans
Söderdahl G; Barkholt L; Hentschke P; Mattsson J; Uzunel M; Ericzon BG; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2003;31(3):183-190
Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation
Jaksch M; Uzunel M; Cangana GM; Remberger M; Mattsson J
Article: BONE MARROW TRANSPLANTATION. 2003;31(4):253-261
Reduced intensity conditioning regimens -: Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma
Hentschke P; Barkholt L; Uzunel M; Mattsson J; Wersäll P; Pisa P; Martola J; Albiin N; Wernerson A; Söderberg M; Remberger M; Thörne A; Ringdén O
Article: BLOOD. 2003;101(2):469-472
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation
Uzunel M; Mattsson J; Brune M; Johansson JE; Aschan J; Ringdén O
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;119(4):1133-1136
The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation
Nordlander A; Uzunel M; Mattsson J; Remberger M
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2002;187(2):475-482
Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency
Westgren M; Ringdén O; Bartmann P; Bui TH; Lindton B; Mattsson J; Uzunel M; Zetterquist H; Hansmann M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2001;123(1):162-169
Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation
Mattsson J; Uzunel M; Remberger M; Tammik L; Omazic B; Levitsky V; Zou JZ; Hentschke P; Ringdén O
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2001;115(4):935-944
Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation
Mattsson J; Uzunel M; Brune M; Hentschke P; Barkholt L; Stierner U; Aschan J; Ringdén O
Article: BONE MARROW TRANSPLANTATION. 2001;28(12):1161-1166
A graft-versus-colonic cancer effect of allogeneic stem cell transplantation
Zetterquist H; Hentschke P; Thörne A; Wernerson A; Mattsson J; Uzunel M; Martola J; Albiin N; Aschan J; Papadogiannakis N; Ringdén O
Article: LEUKEMIA. 2001;15(12):1976-1985
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation
Mattsson J; Uzunel M; Tammik L; Aschan J; Ringdén O
Article: BLOOD. 2001;98(6):1982-1984
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia
Uzunel M; Mattsson J; Jaksch M; Remberger M; Ringdén O
Article: TRANSPLANTATION. 2001;71(3):433-439
T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation
Mattsson J; Uzunel M; Remberger M; Ringdén O
Article: TRANSPLANTATION. 2000;69(10):2043-2048
Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer
Ringdén O; Söderdahl G; Mattsson J; Uzunel M; Remberger M; Hentschke P; Hägglund H; Sparrelid E; Elmhorn-Rosenborg A; Duraj F; Zetterquist H; Ericzon BG
Article: BONE MARROW TRANSPLANTATION. 2000;25(8):843-851
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia
Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Article: LEUKEMIA. 2000;14(2):247-254
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease
Mattsson J; Uzunel M; Remberger M; Ljungman P; Kimby E; Ringdén O; Zetterquist H
Visa fler

Alla övriga publikationer

Published conference paper: BONE MARROW TRANSPLANTATION. 2018;53(1):69-77
Assessment of TREC, KREC and telomere length in long-term survivors after allogeneic HSCT: the role of GvHD and graft source and evidence for telomere homeostasis in young recipients
Gaballa A; Norberg A; Stikvoort A; Mattsson J; Sundberg B; Uzunel M; Remberger M; Uhlin M
Review: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2016;17(10):1705
T Cell Receptor Excision Circle (TREC) Monitoring after Allogeneic Stem Cell Transplantation; a Predictive Marker for Complications and Clinical Outcome
Gaballa A; Sundin M; Stikvoort A; Abumaree M; Uzunel M; Sairafi D; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):47
THE IMPORTANCE OF GRAFT CELL COMPOSITION TO OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
Svenberg P; Ringden O; Uzunel M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):130-131
CLINICAL EXPANSION OF CORD BLOOD DERIVED T CELLS FOR USE AS DONOR LYMPHOCYTE INFUSION AFTER CORD BLOOD TRANSPLANTATION
Okas M; Gertow J; Uzunel M; Karlsson H; Uzunel M; Ringden O; Mattsson J; Ublin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):47
HLA MISMATCHED MSC SUPPRESS T LYMPHOCYTE ALLORESPONSES IN VITRO AND DO NOT INDUCE IMMUNOLOGICAL MEMORY IN RECIPIENTS OF MSC INFUSION
Sundin M; Barrett J; Ringden O; Uzunel M; Lonnies H; Dackland A-L; Christensson B; Le Blanc K
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):144
MINIMAL RESIDUAL DISEASE AND CHIMERISM IN CML PATIENTS RECEIVING ALLOGENEIC TRANSPLANTS AFTER MYELOABLATIVE OR REDUCED CONDITIONING
Uzunel M; Mattsson J; Hauzenberger D; Ringden O
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(2):47
Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon
Ringden O; Uzunel M; Sundberg B; Lonnies L; Nava S; Gotherstrom C; Gustafsson J; Henningsohn L; Le Blanc K
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):40
Sensitive and quantitative chimerism analysis in AML patients with real-time PCR
Svenberg P; Uzunel M; Ringdén O
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):72
No association between MIC-A polymorphism and clinical outcome after allogeneic HSCT
Uzunel M; Remberger M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):2
Mesenchymal stem cells for treatment of severe acute graft-versus-host disease
Ringden O; Uzunel M; Rasmusson I; Remberger ME; Sundberg B; Lonnies H; Marschall HU; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2005;11(2):42
Sensitive and quantitative chimerism analysis in all patients with real-time PCR
Uzunel M; Ulf S; Jonas M; Petter S; Marie S; Dan H; Olle R
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(2):80
Indium-III labelled donor lymphocyte infusion via hepatic artery or IV against liver metastases of renal and colon carcinoma after allogeneic haematopoietic stem cell transplantation
Barkholt L; Danielsson R; Calissendorff B; Svensson L; Malihi R; Uzunel M; Remberger M; Ringden O
Thesis / dissertation: 2003
The methodology and significance of minimal residual disease detection after allogeneic stem cell transplantation
Uzunel, Mehmet
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2001;33(1-2):1862-1864
An allogeneic anti-cancer effect after hematopoietic stem cell transplantation
Barkholt L; Hentschke P; Zetterquist H; Mattsson J; Uzunel M; Wersäll P; Martola J; Albin N; Aschan J; Wijkström H; Tillegård A; Öman S; Wernerson A; Niederwieser D; Thörne A; Ringdén O
Meeting abstract: GASTROENTEROLOGY. 2000;118(4):A1414
Tumor reduction surgery followed by allogeneic stem cell transplantation. A treatment for disseminated gastrointestinal cancer?
Thorne A; Zetterquist H; Hentchke P; Mattsson J; Uzunel M; Aschan J; Ohman S; Ringden O

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2024-2025

Examina och utbildning

Docent, klinisk immunologi, Karolinska Institutet, 2014
MEDICINE DOKTORSEXAMEN, Institutionen för laboratoriemedicin, Karolinska Institutet, 2003

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI